Published in Neurosurgery on March 01, 2005
Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. | NCT05131295
Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol (2010) 1.69
Management of cerebral vasospasm. Neurosurg Rev (2006) 1.18
The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2013) 1.18
Update on subarachnoid haemorrhage. J Neurol (2008) 1.08
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 0.99
Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int (2014) 0.90
Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhage. PLoS One (2011) 0.88
Role of statins in cerebral vasospasm. Acta Neurochir Suppl (2008) 0.82
Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage. Acta Neurochir Suppl (2013) 0.80
Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol (2008) 0.79
Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. Sci Rep (2014) 0.78
The role of statins in neurosurgery. Neurosurg Rev (2010) 0.78
Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management. Neuroradiol J (2013) 0.75
Effect of statins treatment for patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of observational studies and randomized controlled trials. Int J Clin Exp Med (2015) 0.75
Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial. Neurosurgery (2015) 0.75
Towards use of MRI-guided ultrasound for treating cerebral vasospasm. J Ther Ultrasound (2016) 0.75
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Biological invasions: recommendations for U.S. policy and management. Ecol Appl (2006) 3.74
All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ (2011) 3.51
Metacognitive awareness and prevention of relapse in depression: empirical evidence. J Consult Clin Psychol (2002) 3.49
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med (2004) 3.24
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08
Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke (2011) 3.04
NHS emergency response to 999 calls: alternatives for cases that are neither life threatening nor serious. BMJ (2002) 2.86
Continuous electroencephalography in the medical intensive care unit. Crit Care Med (2009) 2.86
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2005) 2.36
Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery (2006) 2.33
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci (2002) 2.25
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19
External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg (2010) 2.15
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia (2002) 2.14
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev (2009) 2.11
Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy. Neurology (2012) 2.07
Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med (2007) 1.97
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage. Neurology (2013) 1.90
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89
Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation (2005) 1.88
Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol (2011) 1.85
Ventriculostomy-related infections: a critical review of the literature. Neurosurgery (2002) 1.84
The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis (2006) 1.83
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Carotid-cavernous fistulas. Neurosurg Focus (2012) 1.76
Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med (2004) 1.76
The effects of extreme heat on human mortality and morbidity in Australia: implications for public health. Asia Pac J Public Health (2011) 1.72
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 1.65
Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med (2009) 1.64
Impact of two recent extreme heat episodes on morbidity and mortality in Adelaide, South Australia: a case-series analysis. Environ Health (2011) 1.64
Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 1.63
Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology (2007) 1.61
Prescribing of antibiotics and admissions for respiratory tract infections in England. BMJ (2004) 1.58
Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA (2004) 1.58
Ischemic brain injury after intracerebral hemorrhage: a critical review. Stroke (2012) 1.57
Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol (2004) 1.55
Treatment guidelines for cerebral arteriovenous malformation microsurgery. Br J Neurosurg (2009) 1.54
The surgical management of chronic subdural hematoma. Neurosurg Rev (2011) 1.54
Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg (2012) 1.53
Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission. Crit Care Med (2013) 1.52
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centres. BMC Musculoskelet Disord (2009) 1.51
Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery (2005) 1.51
Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol (2008) 1.51
Altered coronary vasomotor function in young patients with systemic lupus erythematosus. Arthritis Rheum (2007) 1.49